Abeer Mohamed Rawy Abdel- Monem
Professor
Role of MicroRNA (182) in Differentiation between Benign and Malignant Pleural Effusion
• 2024
Publication Information
Authors
Amira H. Allam, Magdi Omar, hamasat abdelhafez, Abeer M. Rawy, Toqa ayman, Rehab Elsawy
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Abeer Mohamed Rawy Abdel- Monem_paper 8.docx
Abstract
Abstract
Background: There is still a clinical challenge in differentiating between malignant pleural effusion (MPE) and benign pleural effusion (BPE). Aim: to evaluate the role of microRNA (182) in differentiation between tuberculous (TPE) and MPE. Methods: This cross-sectional study involved 60 patients admitted to the Chest Department, Benha University Hospital. Patients were divided into two groups based on pathology results: Group A (n=45): MPE and Group B: (n=15): TPE. miRNA 182 was measured by qt PCR in both groups and expressed as ΔΔCT and fold change(2-ΔΔCt ) Results: No statistically significant difference between MPE and TPE regarding ΔΔCT and fold change and the level did not differ significantly between malignant types. Adenosine deaminase (ADA) can significantly differentiate between malignant and TB groups (P
Background: There is still a clinical challenge in differentiating between malignant pleural effusion (MPE) and benign pleural effusion (BPE). Aim: to evaluate the role of microRNA (182) in differentiation between tuberculous (TPE) and MPE. Methods: This cross-sectional study involved 60 patients admitted to the Chest Department, Benha University Hospital. Patients were divided into two groups based on pathology results: Group A (n=45): MPE and Group B: (n=15): TPE. miRNA 182 was measured by qt PCR in both groups and expressed as ΔΔCT and fold change(2-ΔΔCt ) Results: No statistically significant difference between MPE and TPE regarding ΔΔCT and fold change and the level did not differ significantly between malignant types. Adenosine deaminase (ADA) can significantly differentiate between malignant and TB groups (P